Frequently Asked Questions on Commercial AI Data Brokers & Licensing
Concise legal and commercial answers on broker fee structures, chain-of-title audits, and 2026 per-hour/per-study pricing.
Frequently Asked Dataset Brokerage & Rights Questions
What commission or revenue split do AI data brokers charge in 2026?
Specialized AI data brokers (such as Protege, Troveo, Luel, and Defined.ai) typically retain 20% to 35% of gross licensing proceeds—covering HIPAA/PII scrubbing, schema normalization, legal indemnity, and multi-lab sales—passing 65% to 80% to the underlying rights holder. Passive cloud rails like AWS Data Exchange charge 3% to 8% infrastructure listing fees.
Do off-the-shelf stock video or speech licenses protect against model weight deletion?
Only if explicitly negotiated. Standard stock media agreements omit generative AI weight shields; enterprise AI MSAs must include an explicit Model Weight Disgorgement Waiver limiting third-party claim remedies to monetary indemnity and removal from future training runs.
Why is HIPAA Expert Determination preferred over Safe Harbor for clinical AI datasets?
HIPAA Safe Harbor strips dates, geographic granularity, and ages over 89, often destroying longitudinal clinical progression signals needed by medical AI models. Expert Determination (45 CFR 164.514(b)) statistically certifies minimal re-identification risk while preserving longitudinal clinical utility.
When should an AI lab commission bespoke human data instead of buying from a broker?
License from a broker for foundational multimodal coverage (thousands of hours of 4K physics video, multi-accent ASR, or baseline DICOM imaging). Switch to bespoke first-party creation (Surge AI, Mercor, Luel custom pods) for post-training SFT, RLHF, and private capability holdouts where multi-buyer catalog saturation erases competitive advantage.
Technical & Commercial Reference Scope
All statutory citations (EU AI Act Art. 53, 45 CFR 164.514, 740 ILCS 14) are provided as procurement engineering benchmarks alongside qualified IP counsel review.